Due to the retrospective nature of this study, it cannot be finally determined whether AML patients with a higher CRP need more crystalloid fluids and FO is a largely unavoidable consequence or whether FO promotes infection and inflammation reflected by significantly higher CRP levels. This evidence concerns the gene CRP and acute myeloid leukemia.